Speaker(s): 

Lindsey Burton, MD, Resident Physician, Geisinger - has nothing to disclose.

Ghazal Ghafari, DO, Resident Physician, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Pathology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the appropriateness of venous thromboembolism testing in patients based on screening guidelines
• Analyze the cost burden of ordering venous thromboembolism testing
• Recognize clonally related cutaneous manifestations of myeloid neoplasms and further illuminate the highly diverse spectrum of morphologic and immunophenotypic features they exhibit
• Explain diagnostic pitfalls related to cutaneous manifestations of myeloid neoplasms

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary S. Hoffer, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session: 

None.